Arosa F A, Oliveira L, Porto G, da Silva B M, Kruijer W, Veltman J, de Sousa M
Department of Molecular Immunology and Pathology, Abel Salazar Institute for the Biomedical Sciences, University of Porto, Portugal.
Clin Exp Immunol. 1997 Mar;107(3):548-54. doi: 10.1046/j.1365-2249.1997.d01-967.x.
The present study consists of a phenotypic and functional characterization of peripheral blood T lymphocytes in a group of 21 patients with hereditary haemochromatosis (HH), an MHC class I-linked genetic disease resulting in iron overload, and a group of 30 healthy individuals, both HLA-phenotyped. The HH patients studied showed an increased percentage of CD8+ CD28- T cells with a corresponding reduction in the percentage of CD8+ CD28+ T cells in peripheral blood relative to healthy blood donors. No anomalies of CD28 expression were found in the CD4+ subset. The presence of the HLA-A3 antigen but not age accounted for these imbalances. Thus, an apparent failure of the CD8+ CD28+ T cell population 'to expand', coinciding with an 'expansion' of CD8+ CD28- T cells in peripheral blood of HLA-A3+ but not HLA-A3- HH patients was observed when compared with the respective HLA-A3-matched control group. A significantly higher percentage of HLA-DR+ but not CD45RO+ cells was also found within the peripheral CD8+ T cell subset in HH patients relative to controls. Phytohaemagglutinin (PHA) stimulation of peripheral blood mononuclear cells (PBMC) for 5 days showed: (i) that CD8+ CD28+ T cells both in controls and HH were able to expand in vitro; (ii) that CD8+ CD28- T cells decreased markedly after activation in controls but not in HH patients. Moreover, functional studies showed that CD8+ cytotoxic T lymphocytes (CTL) from HH patients exhibited a diminished cytotoxic activity (approx. two-fold) in standard 51Cr-release assays when compared with CD8+ CTL from healthy controls. The present results provide additional evidence for the existence of phenotypic and functional anomalies of the peripheral CD8+ T cell pool that may underlie the clinical heterogeneity of this iron overload disease. They are of particular relevance given the recent discovery of a novel mutated MHC class I-like gene in HH.
本研究对21例遗传性血色素沉着症(HH)患者和30名健康个体的外周血T淋巴细胞进行了表型和功能特征分析,两组均进行了HLA分型。HH是一种与MHC I类相关的遗传性疾病,可导致铁过载。研究的HH患者外周血中CD8+ CD28- T细胞百分比增加,而CD8+ CD28+ T细胞百分比相应降低,与健康献血者相比。在CD4+亚群中未发现CD28表达异常。这些失衡是由HLA-A3抗原的存在而非年龄导致的。因此,与各自的HLA-A3匹配对照组相比,观察到HLA-A3+而非HLA-A3-的HH患者外周血中CD8+ CD28+ T细胞群体明显未能“扩增”,而CD8+ CD28- T细胞却“扩增”。与对照组相比,HH患者外周CD8+ T细胞亚群中HLA-DR+而非CD45RO+细胞的百分比也显著更高。用植物血凝素(PHA)刺激外周血单个核细胞(PBMC)5天显示:(i)对照组和HH患者的CD8+ CD28+ T细胞在体外均能扩增;(ii)对照组中CD8+ CD28- T细胞激活后明显减少,而HH患者中未减少。此外,功能研究表明,与健康对照的CD8+细胞毒性T淋巴细胞(CTL)相比,HH患者的CD8+ CTL在标准的51Cr释放试验中细胞毒性活性降低(约两倍)。目前的结果为外周CD8+ T细胞库存在表型和功能异常提供了额外证据,这些异常可能是这种铁过载疾病临床异质性的基础。鉴于最近在HH中发现了一个新的突变MHC I类样基因,这些结果具有特别的相关性。